Multifunctional Nitroxide Derivatives for Oxidative Stress
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for oxidative stress and endothelial dysfunction often require co-administration of separate potassium channel openers and antioxidants, which face challenges due to unpredictable tissue distribution, metabolism, and intracellular localization, limiting their effectiveness.
Innovation Solution
Development of multifunctional nitroxide derivatives that combine potassium channel opening and reactive oxygen species degradation properties, specifically the oxy radical of 2-cyano-1-(1-hydroxy-2,2,5,5-tetramethylpyrrolidin-3-yl)-3-(pyridin-3-yl) guanidine, to simultaneously target oxidative stress and endothelial dysfunction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If separate potassium channel openers and antioxidants are co-administered, then therapeutic coverage is improved, but treatment complexity and unpredictability increase
Solution Approach 1:
The patent combines a potassium channel opener (pinacidil) and an antioxidant (tempol) into a single conjugate molecule. This merging of two separate therapeutic agents into one compound allows simultaneous delivery of both functions, reducing treatment complexity while maintaining broad therapeutic coverage for oxidative stress and endothelial dysfunction
Solution Approach 2:
The conjugate molecule serves multiple therapeutic functions simultaneously: it acts as both a potassium channel opener and an antioxidant. This multi-functionality allows a single compound to address multiple pathological mechanisms involved in ischemia-reperfusion injury, inflammatory conditions, and oxidative stress-related diseases
2Adaptability or versatility
If separate potassium channel openers and antioxidants are co-administered, then therapeutic coverage is improved, but reliability decreases due to unpredictable tissue distribution and metabolism
Solution Approach 1:
By covalently linking the potassium channel opener and antioxidant into a single conjugate molecule, the patent ensures that both therapeutic agents are delivered together to the same tissue compartments. This eliminates the variability associated with separate administration, as the fixed molecular structure guarantees consistent co-delivery and metabolic fate
Solution Approach 2:
The conjugate molecule self-delivers both therapeutic functions simultaneously to target tissues. The unified structure ensures that the compound's pharmacokinetic properties (distribution, metabolism, excretion) apply equally to both functional moieties, creating predictable and reliable therapeutic exposure without requiring coordinated administration of separate agents
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These derivatives effectively reduce myocardial and renal injury, attenuate inflammation, and provide protective effects in ischemia-reperfusion injuries and acute chlorine inhalation, without causing systemic hypotension or affecting blood glucose levels.
Implementation Method 1
multifunctional nitroxide derivatives that combine potassium channel opening and reactive oxygen species degradation properties
Implementation Method 2
Openers of the mitochondrial ATP-regulated potassium channel have been shown to provide cytoprotection in experimental models of redox stress
Data Source
Figure 1
Figure 2A~2B
Figure 3A~3C
AI summary
The present invention provides multifunctional nitroxide derivatives comprising a potassium channel opener and a reactive oxygen species (ROS) degradation catalyst that can act as an anti-oxidant, as well as pharmaceutical compositions comprising them. The multifunctional compounds and pharmaceutical compositions of the invention are useful for treatment of diseases, disorders or conditions associated with oxidative stress or endothelial dysfunction.